We came up with a drug cocktail consisting of tocilizumab, which is currently used to treat rheumatoid arthritis, and reparixin, which is currently in clinical trials against breast cancer.
Provammo un cocktail farmacologico di tocilizumab, normalmente usato per trattare l'artrite reumatoide, e reparixin, oggi usato nei test clinici contro cancro al seno.